by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

K.C. Pharmaceuticals, Inc. Warning Letter Details

Warning Letter

K.C. Pharmaceuticals, Inc.

K.C. Pharmaceuticals, Inc., 3420 Pomona Blvd. Pomona , CA 91768 United States

Issue DateAugust 12, 2026

FEI Number2026940

Violations5

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

K.C. Pharmaceuticals, Inc. FDA Warning Letter, August 12, 2026